Pediatric Dermatology

MoleMapCD technology from DigitalDerm allows patients and doctors to monitor potentially deadly changes in the skin with accuracy and objectivity, the company says.

The incidence of melanoma is continuing to increase faster than that of any other cancer in the United States, said Darrell S. Rigel, M.D.

Local treatment with the topical immunomodulator tacrolimus 0.1 percent ointment (Protopic, Fujisawa) may be a useful adjunct in the management of pyoderma gangrenosum (PG), and can some times be used successfully as monotherapy, perhaps particularly for the treatment of peristomal disease, said David Fivenson, M.D.

According to Henry C. McGuire, Jr., M.D., attempts to treat cancerous tumors with immunological therapies are more than 100 years old.

Videodermatoscopy has been demonstrated to have several potential and useful applications in dermatology including parasitoses, hair disorders, as well as other dermatoses, says Giuseppe Micali, M.D.

Palmoplantar pustulosis (palmoplantar pustular psoriasis) presents a frustrating therapeutic challenge to clinicians and a disabling disease for patients deserving of greater research interest from the global dermatology community, says Robert J.G. Chalmers, M.B.B.S.

Pharmaceutical Specialties is demonstrating its Vanicream Sunscreens at the 63rd Annual Meeting here.

Del Pharmaceuticals is displaying its newest product, Dermarest Stretch Mark Repair Cream, at the 63rd Annual Meeting.

Dermatologists should become environmental activists in their communities and on a broader scale, urges Peyton E. Weary, M.D.

Steven A. Rosenberg, M.D., Ph,D., chief of surgery at the National Cancer Institute, Bethesda, Md., received the AAD Cancer Research Award yesterday.

Former AAD president, Rex A. Amonette, M.D., received the Gold Metal award, the highest award given by the Academy, yesterday.

Members of the American Academy of Dermatology and the AAD Association began voting online Sunday for 2006 officers and directors.

The Women's Dermatologic Society celebrated its thirtieth year in existence in an awards luncheon yesterday.

Clay J. Cockerell, M.D., assumes the post of AAD president tomorrow.

Palmoplantar pustulosis (palmoplantar pustular psoriasis) presents a frustrating therapeutic challenge to clinicians and a disabling disease for patients deserving of greater research interest from the global dermatology community, says Robert J.G. Chalmers, M.B.B.S.

As more knowledge is gained into the pathophysiology of atopic eczema, it is important to understand the underlying eliciting factors in the diagnosis and treatment of the condition.

A new approach, cell transfer immunotherapy, can cause regressions in more than half of patients with metastatic melanoma refractory to all other treatments.

Various environmental phenomena can have an effect on human health, such as eliminating the potential for life-saving medications.

Valeant Pharmaceuticals is displaying two new products in its Kinerase line.

PharmaDerm is launching two new marketing campaigns toward dermatologists at the 63rd Annual Meeting.

According to a research study presented yesterday, infliximab (Remicade) was found effective in treating psoriatic arthritis.

Boni E. Elewski, M.D., president of the American Academy of Dermatology (AAD), will award the distinguished presidential citation to 20 members today.

When dermatologist Steven K. Shama, M.D., talks about achieving the unforgettably positive office visit, he refers to "being in the moment" with each patient.

While the popular media has sold the idea that DNA is the only factor in genetic diseases, environment actually plays a large role, according to Lowell Goldsmith, M.D., University of North Carolina Chapel Hill School of Medicine.

Categorizing urticaria and following up with effective treatment can prove to be very challenging to the clinician, says Aniko Kobza Black M.D.